CBS 2019
CBSMD教育中心
中 文

药物涂层球囊

Abstract

Recommended Article

Comparison of 2 Different Drug-Coated Balloons in In-Stent Restenosis: The RESTORE ISR China Randomized Trial Drug-Coated Balloon for De Novo Coronary Artery Disease: JACC State-of-the-Art Review Long-term clinical outcomes after treatment of stent restenosis with two drug-coated balloons Percutaneous Treatment and Outcomes of Small Coronary Vessels: A SCAAR Report Benefits with drug-coated balloon as compared to a conventional revascularization strategy for the treatment of coronary and non-coronary arterial disease: a comprehensive meta-analysis of 45 randomized trials 3-Year Clinical Follow-Up of the RIBS IV Clinical Trial A Prospective Randomized Study of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis in Coronary Arteries Previously Treated With Drug-Eluting Stents Survival After Coronary Revascularization With Paclitaxel-Coated Balloons Drug-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation in Patients With Coronary Stent Restenosis

Original Research2015 Aug;31(6):1251-9.

JOURNAL:Int J Cardiovasc Imaging. Article Link

Diagnostic performance of transluminal attenuation gradient and fractional flow reserve by coronary computed tomographic angiography (FFR(CT)) compared to invasive FFR: a sub-group analysis from the DISCOVER-FLOW and DeFACTO studies

Nakanishi R, Matsumoto S, Alani A et al. Keywords: coronary computed tomographic angiography; coronary artery disease; fractional flow reserve derived from CCTA; lesion-specific ischemia; diagnostic accuracy

FULL TEXT PDF